Company intelligence / Profile preview

Crestone Commercial Construction

Boulder, Colorado, United Statescrestoneconstructs.com ↗

Ownership: Private
Development stage: Other

Overview

Crestone has reported positive results from a Phase 2 trial of CRS3123 for C. difficile infection, meeting primary endpoints with high cure rates and low recurrence. The company has received significant NIH funding to support further development and manufacturing optimization[6][8][9].

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Partnerships

National Institute of Allergy and Infectious Diseases (NIAID)National Institutes of Health (NIH)

Beyond the preview

Go deeper on Crestone Commercial Construction.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crestone Commercial Construction.

Explore the full profile